Home News & Views

News & Views

FILTER:

Abzena and Telix Sign Licence Agreement for Abzena’s Prostate-Specific Membrane Antigen Antibodies

Telix is pleased to announce a licence agreement collaboration with Abzena plc (Abzena) for its prostate-specific membrane antigen antibodies (PSMA).
Read more

Telix Pharmaceuticals and Atlab Pharma Conclude Therapeutic Product Development Agreement for Prostate Cancer

Telix is pleased to announce the completion of a product collaboration and purchase option agreement with Atlab Pharma SAS (Atlab).
Read more

Telix Pharmaceuticals Acquires Glioblastoma Program from Therapeia

Telix is pleased to announce a product development partnership with Therapeia GmbH & Co KG (“Therapeia”).
Read more